Harvest Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-48,503
| Closed | -$7.33M | – | 65 |
|
|
2022
Q3 | $7.33M | Buy |
48,503
+6,900
| +17% | +$1.04M | 5.92% | 3 |
|
|
2022
Q2 | $6.06M | Buy |
41,603
+38,970
| +1,480% | +$5.68M | 7% | 3 |
|
|
2022
Q1 | $312K | Sell |
2,633
-17
| -0.6% | -$2.01K | 0.27% | 33 |
|
|
2021
Q4 | $365K | Buy |
2,650
+250
| +10% | +$34.4K | 0.21% | 36 |
|
|
2021
Q3 | $333K | Buy |
2,400
+200
| +9% | +$27.8K | 0.23% | 33 |
|
|
2021
Q2 | $214K | Buy |
+2,200
| New | +$214K | 0.14% | 35 |
|
|
2020
Q1 | – | Sell |
-4,721
| Closed | -$257K | – | 47 |
|
|
2019
Q4 | $257K | Sell |
4,721
-1,279
| -21% | -$69.6K | 0.51% | 31 |
|
|
2019
Q3 | $250K | Sell |
6,000
-3,900
| -39% | -$163K | 0.35% | 30 |
|
|
2019
Q2 | $434K | Buy |
+9,900
| New | +$434K | 0.6% | 28 |
|